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Abstract. micrornas (mirnas) mir15a and let7a are 
important regulators of bcl-2, ras and c-myc proteins. 
considering that these mirnas are commonly altered in 
many human cancers and that these proteins are reported 
to be altered in oral squamous cell carcinoma (OScc), we 
investigated them in a set of OScc cases. the mirnas 
as well as the proteins were evaluated in the tumor and 
blood of 20 patients by real-time quantitative pcr and 
immunohistochemistry, respectively. the expression of 
mir15a and bcl-2 proteins in the tumors was not associated 
with each other or with tumor staging. On the other hand, 
we found reduced expression of this mirna in the blood of 
patients with an advanced stage of OScc and with lymph node 
metastasis. the expression of let7a in the tumor and blood was 
not associated with tumor size, lymph node metastasis, tumor 
staging and immunoexpression of ras and c-myc proteins. in 
conclusion, the present study shows that reduced expression of 
mir15a is associated with OScc staging.
Introduction
micrornas (mirnas) are small non-coding evolution-
arily conserved rnas which mediate gene expression at 
the post-transcriptional level by degrading or repressing 
target messenger rna (mrna) (1,2). mirnas are products 
approximately 22 nucleotides long which regulate mrna 
translational by base pairing to partially complementary sites, 
predominantly in the 3' untranslated region (3'utr) (2). each 
mirna has the potential to regulate many target genes in 
humans, modulating the levels of thousands of mrnas, which 
implies that over one third to one half of all protein-encoding 
genes in humans are regulated by mirnas (3). considering 
the important effect of mirnas on gene expression, it is 
not surprising that these small rnas have been implicated 
in the pathogenesis of cancer (4). The expression profiles of 
mirnas are usually altered in many cancers. a reduction in 
mirnas accelerates oncogenic transformation through the 
deregulation of target oncogenes (5). Oncogenic mirnas 
have also been described and have been shown to be involved 
in the pathogenesis of some tumors. in this case, the increased 
transcription of mirna inactivates a tumor-suppressor gene. 
Oral squamous cell carcinoma (OScc) is one of the most 
frequent cancers in the world, and its main risk factors include 
smoking and alcohol consumption. this neoplasia results from 
multiple genetic events, resulting in damage to signalling path-
ways and the regulation of the cell cycle. the 5-year survival 
rate for cancers of the tongue, oral cavity and oropharynx is 
approximately 50% (6). despite the importance of mirnas 
in human cancer, few studies have attempted to evaluate their 
expression in oral cancer (7). in the present study, we selected 
two mirnas (mir15a and let7a) that are commonly altered 
in different types of cancer. We also chose these mirnas as 
they regulate the expression of proteins reported to be altered 
in OScc (bcl-2, ras and c-myc). the results showed decreased 
expression of mir15a in the blood of patients with advanced 
stage OScc and lymph node metastasis.
Materials and methods
a total of 20 primary tumors and peripheral blood were 
obtained from 20 patients with OScc immediately after 
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surgical resection. the average age of the patients was 
57 years (range, 37-90 years), and they were predominantly 
male. Histological classification was performed according to 
the International Histological Classification of Tumors (8) and 
the tnm staging system according to the international union 
against cancer (uicc). 
the tissue samples were collected in rnaholder 
(Bioagency, Sao paulo, Brazil). all samples were collected at 
the time of surgery. a section of the lesion was immediately 
snap frozen and stored at -80˚C. The other part was fixed 
in buffered formalin for histopathological diagnosis. 
Histopathological analysis confirmed that each tissue sample 
had a >60% tumor cell content. the peripheral blood (4 ml) 
was collected immediately after surgical resection of the 
primary tumor. the blood was collected in a tube with 
anticoagulant (EDTA) and stored at -80˚C until processing. 
Fragments of normal oral mucosa and the peripheral blood 
of healthy volunteers were collected during non-neoplastic or 
preprosthetic surgical procedures and were used as control. 
the present study was approved by the local ethics committee, 
and a signed informed consent was obtained from all of the 
patients as well as the healthy volunteers.
total rna was isolated from 25 mg of human frozen 
samples and 250 µl of peripheral blood sample in 1 ml of 
trizol reagent (invitrogen life technologies, inc., carlsbad, 
ca, uSa), according to the manufacturer's instructions. 
The RNA was briefly treated with RNAse-free DNAase I 
(invitrogen life technologies), and the cdna was synthetized 
from 1 µg of total RNA using gene-specific stem-loop primers 
to mirna (9) (taqman microrna rt; applied Biosystems, 
Foster City, CA, USA). The expression of miRNA was profiled 
using a real-time quantitative taqman assay (taqman® 
microrna assays; applied Biosystems) in a Step-One 
real-time pcr 48-well plate (applied Biosystems). the 20 µl 
total reaction included 2 µl of cdna, 2x taqman universal 
pcr master mix (no emperase unG) and probe mix of the 
taqman microrna assay protocol (applied Biosystems). 
the pcr triplicate reaction was performed in a 48-well 
optical plate at 95˚C for 10 min, followed by 15 sec at 95˚C 
and 1 min at 60˚C for 40 cycles. The mean of the threshold 
cycle (Ct), defined as the fractional cycle number at which 
the fluorescence passes the fixed threshold, was determined 
using default threshold settings. relative gene expression was 
calculated using the 2-ΔΔCt method (applied Biosystems user 
Bulletin no. 2) as previously described (10), and the expres-
sion data were normalized with endogenous mirna rnu48, 
u47 and rnu44. the data were presented as log10 of the 
relative quantity of target mirna normalized to endogenous 
mirna and relative to a calibrator sample. as calibrator we 
used a pool of normal oral tissues for the tumoral tissues, and 
blood samples of healthy individuals for the blood of patients 
with OScc.
the total rna input ranged from 6.25 to 100 ng. the 
results showed that the method was able to detect mirna 
in as little as 10 or 100 ng of total rna. as the amount of 
cDNA was decreased, the amplification started later, giving a 
higher ct. We used 10 ng of rna for all experiment to obtain 
a good balance between cdna economy and an assay of good 
quality. For the let7a, the slope value was -3.329 and r2 was 
0.979. the mir15a experiments showed a slope value of -3.28 
and r2 of 0.987. the endogenous control rnu44, u47 and 
rnu48 showed similar values (slope = -3.33 and r2 = 0.981).
the following antibodies were used for immunohisto-
chemical analysis: bcl-2 (diluted 1:20, clone 124; dako® corp., 
carpinteria, ca, uSa), c-myc (diluted 1:75, clone 3c117; 
Santa cruz® Biotechnology inc., Santa cruz, ca, uSa) and 
h-ras (diluted 1:20, clone F235; Santa cruz Biotechnology). 
immunohistochemical stains were performed using the high 
sensitive polymer-based system (envision; dako corp.) with 
diaminobenzidine substrate solution as chromogen (Sigma, 
St louis, mO, uSa). in the immunohistological analysis, 
only sections containing sufficient neoplasic epithelium were 
used to assess the antibody reactivity. two experienced inde-
pendent pathologists examined multiple fields and scored the 
tissue sections for the extent of staining, regardless of staining 
intensity (score 0, negative staining; score 1, 0-25% of positive 
cells; score 2, 25-50% of positive cells; score 3, >50% of posi-
tive cells).
Statistical methods. non-parametric Spearman correlation 
coefficients were used to assess the association between 
continuous variables. the non-parametric mann-Whitney test 
was used to compare two groups of cases on one variable. 
Statistical analyses were performed using BioStat 4.0 software 
(Optical digital Optical technology, Belém, Brazil), and a 
p-value ≤0.05 was considered statistically significant. 
Results
the gender, age, location, tnm, tumor staging and mirna 
expression in the tumor and blood of patients with OScc are 
presented in table i.
Expression of mir15a in OSCC. compared to normal oral 
tissues, increased expression of mir15a was found in 14 cases 
of OScc (87.5%). the median level of mir15 expression in the 
tumors of early stages (i, ii and iii) was not different when 
compared with that of tumors in an advanced stage (table i). 
no statistical difference was found according to tumor size 
and lymph node metastasis. 
Expression of mir15a in the blood samples. While decreased 
expression of mir15a was found in the blood samples of 
6 patients with OScc (35.2%), increased expression was 
observed in 11 cases (64.8%) (table i). all of the cases with 
decreased expression of mir15a in the blood were OScc cases 
in an advanced stage (stage iv) with lymph node metastasis. 
therefore, reduced expression of this mirna in the blood 
was associated with an advanced stage of the tumor (p=0.006) 
(Fig. 1) and with lymph node metastasis (p=0.010) (Fig. 2). 
the levels of mir15a expression in the blood samples of 
patients with OScc were clearly lower than the levels in the 
matched tumor samples (p=0.034).
mir15a and bcl-2 protein expression. Only sections containing 
sufficient neoplasic epithelium were examined. Positive 
labeling for bcl-2 protein was observed in 4 samples of OScc 
(score 1). the expression of mir15a in the cases with nega-
tive immunostaining for bcl-2 was not statistically different 
compared to the lesions with positive labeling.
experimental and therapeutic medicine  1:  217-221,  2010 219
Expression of let7a in OSCC. While higher levels of let7a 
expression in OScc compared to normal oral mucosa were 
found in 13 cases (61.9%), decreased expression was found 
in 18 cases (38.1%) (table i). the expression of let7a was 
not associated with tumor size, lymph node metastasis and 
tumor stage.
Expression of let7a in blood samples. decreased expression of 
let7a was found in the majority (18 out of 20) of blood samples 
of patients with OScc (table i). the expression of let7a in 
the blood was significantly lower than that in the matched 
tumors. no statistical association was found regarding lymph 
node metastasis and tumor size. no statistical correlation was 
found between the expression of let7a and mir15a.
table i. Gender, age, location, tnm, tumor staging, let7a and mir15a mirna expression in the blood and tumors of oral 
squamous cell carcinoma patients included in the study.
case Gender age location tnm Stage let7a expressiona mir15a expressiona
 -------------------------------- ----------------------------------------
      Blood tumor Blood tumor
  1 m 56 retromolar trigone t2n2m0 iv 1.119   0.512     0.490       3.944
  2 m 55 Floor of the mouth t3n0m0 iii 0.864   2.506   10.446 -
  3 F 61 tongue t4n2m0 iv 0.784   4.075     0.129     12.554
  4 m 49 Floor of the mouth t3n0m0 iii 4.662   0.713     0.462 -
  5 m 51 tongue t2n0m0 ii 3.969   1.289     1.543       3.144
  6 F 68 tongue t4n1m0 iv -   0.004 -       3.683
  7 m 56 retromolar trigone t4n0m0 iv -   0.782 - -
  8 F 41 tongue t3n0m0 iii 0.020   1.221     0.546       5.579
  9 M 59 Gingiva + floor of the mouth T4N0M0 IV 0.595   7.705     0.249       1.965
10 m 55 retromolar trigone t4n1m0 iv 0.003 41.144     0.005       0.032
11 m 44 Floor of the mouth t4n0m0 iv 0.557   2.370     2.084     18.466
12 m 37 Floor of the mouth t4n0m0 iv 0.001   1.448     0.599 1265.276
13 m 59 tongue t2n0m0 ii 0.079   0.634     3.693     14.739
14 m 74 Gingiva t4m0m0 iv 6.545   1.265     2.319       1.568
15 F 50 Floor of the mouth t2n0m0 ii 4.509   0.403     4.084       3.498
16 m 73 retromolar trigone t2n0m0 ii 0.934   0.388     4.029       0.220
17 m 72 Floor of the mouth t4n3m0 iv 0.488   8.066     0.429   162.979
18 m 61 Floor of the mouth t2n0m0 ii 4.415 41.087     2.134   226.736
19 m 68 tongue + retromolar trigone t3n0m0 iii 3.236   1.495 121.275       5.499
20 m 73 Gingiva t4n0m0 iv 8.196 34.967     3.517   325.293
a2-ΔΔCt
Figure 1. Relative quantification (2-ΔΔCt) of mir15a in oral squamous cell 
carcinoma stage i-iii compared to stage iv. decreased mir15a expression was 
noted in the tumors with stage iv (p=0.006).
Figure 2. Relative quantification (2-ΔΔCt) of mir15a in oral squamous cell 
carcinoma without lymph node metastasis (n-) compared with positive 
lymph node metastasis (n+). decreased mir15a expression was noted in the 
n+ cases (p=0.010).
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Let7a and c-myc or ras protein expression in OSCC. most 
of the samples (14 out of 20) presented moderate (score 2) or 
strong (score 3) c-myc expression. the expression of let7a in 
the cases with c-myc score 2 was not statistically different 
when compared to the expression of let7a in the cases with 
c-myc score 3. all cases with decreased expression of let7a 
showed strong positive staining for c-myc, but this association 
was not statistically significant. 
most of the samples were positive for the ras protein. the 
expression of let7a in the cases with ras staining score 1 was 
not statistically different when compared to the expression of 
let7a in the cases with ras staining score 3.
Expression of bcl-2, c-myc and ras regarding tumor staging. 
no relationship was observed between expression of bcl-2, 
c-myc and ras with tumor staging.
Discussion
tran et al (11) investigated 261 mature mirna genes in nine 
head and neck cancer cell lines using an oligonucleotide 
array platform. the cell lines were from carcinomas of the 
hypopharynge, tongue, larynx and tonsil. the authors found 
overexpression of 33 mirnas, and 22 exhibited low expres-
sion. another study showed that cancer cell lines from head 
and neck overexpress mir-205r (12). One important limitation 
of these studies was the use of cancer cell lines for investiga-
tion. mirna from cancer cell lines may not show the same 
profile as the original tumor. According to some researchers, 
in vitro growth conditions including the inclusion of synthetic 
medium and fetal bovine serum may have an effect on mirna 
expression patterns in human tumor cell lines (13).
evidence suggests that mirnas may control cancer 
development, or at least play a critical role in the pathogenesis 
through regulation of cell growth and apoptosis. the associa-
tion of mirnas with the expression of important oncogenes 
such as bcl-2, c-myc and ras supports a key role for these small 
molecules in human cancer.
diminished or loss of expression of mir15a has been 
demonstrated in chronic lymphocytic leukemia and in 
prostate cancer (14). the 3'utr of the bcl-2 transcript has 
potential binding sites for mir15a and mir16-1, and these 
mirnas have the ability to downregulate the anti-apoptotic 
protein bcl-2 (15). Furthermore, the expression of this mirna 
induces apoptosis in leukemia cell lines. considering that 
OScc shows altered expression of bcl-2 (16) we attempted 
to investigate the association between this mirna and its 
target protein, together with its impact on clinical staging. We 
observed increased expression of mir15a in most of the OScc 
cases, which may be associated with the negative staining 
found for bcl-2 in many of the samples studied. however, we 
did not observe any statistical significant association between 
this mirna and this anti-apoptotic protein. the lack of 
association between both may be explained by other proteins 
or regulators of bcl-2 apart from mir15a which are also able to 
influence bcl-2 expression. For example, bcl-2 expression may 
be regulated by tyrosine kinase inhibitors that can regulate 
apoptosis and inhibit bcl-2 expression. bcl-2 phosporylation 
may be another regulatory mechanism of bcl-2 protein 
expression (17). 
We did not find an association between mir15a expres-
sion in OScc and tumor staging, tumor size and lymph node 
metastasis. notably, reduced expression of mir15a was found 
in the blood of patients with lymph node metastasis or in 
advanced clinical staging (stage iv) compared to stages i, ii 
and iii. loss of heterozygosity of 13q.14.3, the same locus of 
mir15a, was previously reported in OScc and was correlated 
with lymph node metastasis (18). these data further support 
the importance of chromosome 13q in the pathogenesis of 
OSCC. These findings also suggest that the expression of this 
tumor-supressor mirna in the blood of patients with OScc 
may also be useful in tumor staging. 
considering the methodology used in the present study, 
it is not possible to know the origin of mir15a found in the 
blood. the possible sources of this mirna include circulating 
leukocytes, cancer cells or their products that have reached the 
circulation. although the decreased expression of this mirna 
may have an impact in the expression of bcl-2 in potentially 
metastatic cancer cells in the blood, this hypothesis needs to 
be tested.
We did not find an association between let7a expression 
and OSCC staging. Reduced expression of let7a was signifi-
cantly associated with shortened postoperative survival in 
patients with lung cancer. Furthermore, let7a overexpression 
results in the inhibition of lung cancer cell growth (19), as well 
as the growth of human colon cancer cells (20). recent studies 
have shown an association between mirna expression, such 
as let7 and mir-205, and the severity and poor survival in 
patients with head and neck cancer (21,22). Our data did not 
confirm a tumor-suppressor role for let7a in the pathogenesis 
of OScc.
let7 mirna negatively regulates the expression of ras and 
c-myc by targeting their mrnas for translation repression 
(23). in lung cancer, reduced levels of let7 were observed 
together with increased expression of the ras protein (19). 
The presence of any ras variant was significantly associated 
with poor prognosis in squamous cell carcinoma of the 
head and neck, and prognosis was worse among cases of 
oral cancer (24). Studies of ras expression in squamous cell 
carcinoma of the head and neck have indicated that amplified 
ras promotes growth, and the presence of the ras protein has 
been associated with late stage tumors and increased tumor 
size (25). most of the OScc cases in the present study were 
positive for the ras protein, but the expression of this protein 
was not associated with let7 expression or with tumor size or 
lymph node metastasis. 
Overexpression of c-myc has been observed in 20-40% 
of OScc cases. Overexpression of c-myc provides changes 
in the regulation of many genes and contributes to malignant 
transformation (26). in our study, we observed moderate or 
strong c-myc expression in most of the samples studied. the 
amplification status of the myc gene has often been studied 
in parallel with ras. h-ras mutations have been described 
in OScc, but the exact mechanism accounting for ras 
overexpression is unknown, and its association with existing 
prognostic factors is still unclear. a high level of c-myc 
expression is associated with shortened overall survival, tumor 
size and clinical stage (26,27). in our study no relationship was 
found between c-myc protein and tumor staging. as we did 
not find an association between let7a expression with ras or 
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c-myc protein immunolocalization, other genetic or epigenetic 
alterations may be more relevant to the expression of these 
oncogenes in OScc. 
Although the findings here reported are informative, the 
phenomenon of genomic convergence (clonal adaptation) 
should be considered in the critical analysis of the data. 
according to this theory, early stage tumors are karyotypically 
heterogeneous, while late stage tumors are often found to be 
karyotypically homogeneous due to selection pressures (28). 
therefore, it is not possible to know which of the lesions 
included in the analysis were before, during or after genomic 
convergence. despite the limited number of samples, the 
present study shows that reduced expression of mir15a in the 
blood is associated with OScc staging.
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